Johnson and Johnson has delayed the rollout of its Covid vaccine in Europe after regulators in the United States called for a pause because of safety concerns.
The
vaccine is marketed under the brand name Janssen in Europe.
Six people who'd had the
vaccine in the US have developed rare and severe blood clots. It's so far been given to around seven million Americans.
